Tiffany M Mills, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1709 Ky Route 321, Suite 3, Prestonsburg, KY 41653 Phone: 606-886-8546 Fax: 606-886-8548 |
Kristy Kate Shutts, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4851 Ky Route 321, Prestonsburg, KY 41653 Phone: 606-886-1173 Fax: 606-886-2193 |
Dr. Antoin Hana, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4851 Ky Route 321, Prestonsburg, KY 41653 Phone: 606-886-1173 Fax: 606-886-2193 |
Mr. Mazen Jaafar, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5000 Ky Route 321 Ste 3124, Prestonsburg, KY 41653 Phone: 606-886-7635 Fax: 606-886-7680 |
Dr. Rakesh Sachdeva, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 104 S Front Ave, Prestonsburg, KY 41653 Phone: 606-886-8572 Fax: 606-886-4433 |
News Archive
Central Admixture Pharmacy Services, Inc. (CAPSĀ®), a B. Braun company, announced today the launch of its newest service for the admixture and delivery of Hibernation Therapeutics' patented Adenocaineā¢ microplegia, the world's first low-potassium, non-depolarizing cardioplegia solution.
A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.
The Epilepsy Therapy Project, a non-profit organization dedicated to accelerating new therapies for people living with epilepsy, today released presentation highlights following its successful 2010 Epilepsy Pipeline Update Conference held in San Francisco. Sponsored by ETP, this conference brings together leading clinical investigators, emerging CNS companies and academic innovators with investors and business development partners to facilitate professional collaboration, funding and partnerships that will accelerate patient access to new treatments.
There are five subtypes of breast cancer, and they are distinct diseases with vastly different biologies that drastically alter their progression and responses to treatment. Understanding those differences is the starting point to a more effective, personalized treatment of breast cancer, which strikes more than 230,000 women in the U.S. each year.
› Verified 7 days ago